Skip to main content
Acta Crystallographica Section E: Crystallographic Communications logoLink to Acta Crystallographica Section E: Crystallographic Communications
. 2019 Jan 11;75(Pt 2):202–207. doi: 10.1107/S2056989019000458

Three closely related 1-[(1,3-benzodioxol-5-yl)methyl]-4-(halobenzo­yl)piperazines: similar mol­ecular structures but different inter­molecular inter­actions

Ninganayaka Mahesha a, Belakavadi K Sagar a, Hemmige S Yathirajan a,*, Tetsundo Furuya b, Tomoyuki Haraguchi b, Takashiro Akitsu b, Christopher Glidewell c
PMCID: PMC6362650  PMID: 30800451

Three 1-[(1,3-benzodioxol-5-yl)methyl]-4-(halobenzo­yl)piperazines adopt very similar mol­ecular conformations but, while the mol­ecules of the 3-fluoro­benzoyl are linked by hydrogen bonds into a three-dimensional structure, there are no hydrogen bonds in either of the 2,6-di­fluoro­benzoyl and 2,4-di­chloro­benzoyl analogues.

Keywords: piperazines, crystal structure, mol­ecular conformation, hydrogen bonding, supra­molecular assembly

Abstract

In each of the compounds 1-[(1,3-benzodioxol-5-yl)methyl]-4-(3-fluoro­benzo­yl)piperazine, C19H19FN2O3 (I), 1-[(1,3-benzodioxol-5-yl)methyl]-4-(2,6-di­fluoro­benzo­yl)piperazine, C19H18F2N2O3 (II), and 1-[(1,3-benzodioxol-5-yl)methyl]-4-(2,4-di­chloro­benzo­yl)piperazine, C19H19Cl2N2O3 (III), the piperazine rings adopt a chair conformation with the (1,3-benzodioxol-5-yl)methyl substituent occupying an equatorial site: the five-membered rings are all slightly folded across the O⋯O line leading to envelope conformations. The dihedral angle between the planar amidic fragment and the haloaryl ring is 62.97 (5)° in (I) but 77.72 (12)° and 75.50 (5)° in (II) and (III), respectively. Despite their similarity in constitution and conformation, the supra­molecular inter­actions in (I)–(III) differ: in (I), a combination of C—H⋯O and C—H⋯π(arene) hydrogen bonds links the mol­ecules into a three-dimensional framework structure, but there are no hydrogen bonds of any sort in either (II) or (III), although the structure of (III) contains a short Cl⋯Cl contact between inversion-related pairs of mol­ecules.

Chemical context  

1-[(1,3-Benzodioxol-5-yl)meth­yl]piperazine is an important inter­mediate for the synthesis (Duncton et al., 2006; Hamid & Williams, 2007) of piribedil, 1-[(1,3-benzodioxol-5-yl)meth­yl]-4-(pyrimidin-2-yl)piperazine, which is used in the treatment of Parkinson’s disease, particularly in the reduction of tremor (Rondot & Ziegler, 1992; Millan et al., 2001). The synthetic routes to piribedil reported hitherto have utilized either palladium-catalysed (Duncton et al., 2006) or ruthenium-catalysed (Hamid & Williams, 2007) processes, requiring extensive purification procedures to ensure that the final product is free of heavy metals. With this in mind, we have now synthesized a series of N-aroyl analogues (I)–(III) (Figs. 1–3 ) using a metal-free procedure involving a straightforward coupling reaction between 1-[(1,3-benzodioxol-5-yl)meth­yl]piperazine and a carb­oxy­lic acid, promoted by 1-(3-di­meth­yl­amino­prop­yl)-3-ethyl­carbodimide as the dehydrating agent, and we report here the mol­ecular and supra­molecular structures of compounds (I)–(III).graphic file with name e-75-00202-scheme1.jpg

Figure 1.

Figure 1

The mol­ecular structure of compound (I) showing the atom-labelling scheme. Displacement ellipsoids are drawn at the 50% probability level.

Figure 2.

Figure 2

The mol­ecular structure of compound (II) showing the atom-labelling scheme. Displacement ellipsoids are drawn at the 50% probability level.

Figure 3.

Figure 3

The mol­ecular structure of compound (III) showing the atom-labelling scheme. Displacement ellipsoids are drawn at the 50% probability level.

Structural commentary  

In each of (I)–(III), the five-membered ring is slightly non-planar: while the atoms O11, C7A, C3A and O13 are co-planar, as expected, the atom C12 is slightly displaced from this plane by 0.150 (2), 0.099 (6) and 0.210 (2) Å in (I)–(III), respectively, giving an envelope conformation in each case, with the ring folded across the line O11⋯O13. The piperazine rings all adopt chair conformations with the substituent at atom N1 in an equatorial site, while the atoms of the amide fragment (C3, N4, C5, C47, O47 and C41) are coplanar. The only significant conformational difference between the mol­ecules in (I)–(III) lies in the dihedral angle between the amide unit and the adjacent aryl ring (C41–C46), 62.97 (5)° in (I) but 77.72 (12) and 75.50 (5)° in (II) and (III), respectively. The mol­ecules of (I)–(III) exhibit no inter­nal symmetry and hence they are all conformationally chiral, but the space groups (Table 2) confirm that equal numbers of the two conformational enanti­omorphs are present in each crystal.

Table 2. Experimental details.

  (I) (II) (III)
Crystal data
Chemical formula C19H19FN2O3 C19H18F2N2O3 C19H18Cl2N2O3
M r 342.36 360.35 393.25
Crystal system, space group Monoclinic, P21/n Orthorhombic, P c a21 Monoclinic, P21/n
Temperature (K) 173 173 173
a, b, c (Å) 12.2358 (16), 10.3185 (14), 14.2310 (19) 14.2762 (9), 15.9821 (10), 7.3753 (5) 12.2889 (14), 12.3034 (14), 13.3667 (15)
α, β, γ (°) 90, 111.199 (2), 90 90, 90, 90 90, 116.295 (1), 90
V3) 1675.2 (4) 1682.78 (19) 1811.9 (4)
Z 4 4 4
Radiation type Mo Kα Mo Kα Mo Kα
μ (mm−1) 0.10 0.11 0.38
Crystal size (mm) 0.48 × 0.29 × 0.28 0.91 × 0.35 × 0.17 0.49 × 0.48 × 0.38
 
Data collection
Diffractometer Bruker APEXII CCD Bruker APEXII CCD Bruker APEXII CCD
Absorption correction Multi-scan (SADABS; Bruker, 2015) Multi-scan (SADABS; Bruker, 2015) Multi-scan (SADABS; Bruker, 2015)
T min, T max 0.813, 0.972 0.587, 0.981 0.776, 0.867
No. of measured, independent and observed [I > 2σ(I)] reflections 8635, 3674, 2975 9016, 3743, 3449 9718, 4054, 3545
R int 0.021 0.057 0.017
(sin θ/λ)max−1) 0.651 0.650 0.648
 
Refinement
R[F 2 > 2σ(F 2)], wR(F 2), S 0.040, 0.114, 1.10 0.054, 0.155, 1.16 0.031, 0.087, 1.04
No. of reflections 3674 3743 4054
No. of parameters 226 235 235
No. of restraints 0 1 0
H-atom treatment H-atom parameters constrained H-atom parameters constrained H-atom parameters constrained
Δρmax, Δρmin (e Å−3) 0.24, −0.18 0.17, −0.22 0.37, −0.38
Absolute structure Flack x determined using 1369 quotients [(I +)−(I )]/[(I +)+(I )] (Parsons et al., 2013)

Computer programs: APEX2 (Bruker, 2004) SAINT (Bruker, 2013), SHELXS97 (Sheldrick, 2015), SHELXL2014 (Sheldrick,2015) and PLATON (Spek, 2009).

Supra­molecular features  

Despite their similar mol­ecular constitutions and conformations, compounds (I)–(III) all exhibit different types of direction-specific inter­molecular inter­actions. In the crystal structure of compound (I), a combination of one C—H⋯O hydrogen bond and two C—H⋯π(arene) hydrogen bonds (Table 1) links the mol­ecules into a three-dimensional framework structure, whose formation can readily be analysed in terms of simple sub-structures (Ferguson et al., 1998a ,b ; Gregson et al., 2000). The C—H⋯O hydrogen bond links mol­ecules related by the 21 screw axis along (0.25, y, 0.25) to form a C(5) (Etter, 1990; Etter et al., 1990; Bernstein et al., 1995) chain running parallel to the [010] direction. In addition, the C—H⋯π(arene) hydrogen bond having atom C5 as the donor links mol­ecules related by the 21 screw axis along (0.75, y, 0.25) into a second chain running parallel to [010] and, together, these two inter­actions generate a sheet lying parallel to (001) (Fig. 4). The second C—H⋯π(arene) hydrogen bond, having atom C45 as the donor, links mol­ecules related by the n-glide plane at y = 0.75 into a chain running parallel to the [10Inline graphic] direction (Fig. 5), and chains of this type link the (001) sheets into a continuous three-dimensional structure. It is inter­esting to note that both C—H⋯π(arene) hydrogen bonds utilize the same ring as the acceptor, with one donor approaching each face of this ring (Fig. 6), with the angle H5iCg1⋯H45ii = 152°, where Cg1 represents the centroid of the ring (C3A, C14, C15, C16, C17, C7A) and the symmetry codes are (i) Inline graphic − x, −Inline graphic + y, Inline graphic − z) and (ii) (Inline graphic + x, Inline graphic − y, −Inline graphic + z). Hence, the two mol­ecules providing the donor atoms here are related by inversion across (1, 1/2, 0). In this structure, the atoms of type O11 in the mol­ecules at (x, y, z) and (2 − x, 1 − y, −z) are separated by a distance of only 2.7888 (18) Å. At the same time, the atoms C12 and H12 at (x, y, z) are distant from O11 at (2 − x, 1 − y, −z) by 2.66 and 3.008 (2) Å, respectively, with an associated C—H⋯O angle of 101°; the H⋯O distance is too long and the C—H⋯O angle is too small for this contact to be regarded as a hydrogen bond, but the short O⋯O distance here is perhaps associated with this ‘failed’ hydrogen bond involving atom C12.

Table 1. Hydrogen-bond geometry (Å, °) for (I) .

Cg1 represents the centroid of the C3A, C14, C15, C16, C17, C7A ring.

D—H⋯A D—H H⋯A DA D—H⋯A
C42—H42⋯O47i 0.95 2.34 3.273 (2) 168
C5—H5ACg1ii 0.99 2.76 3.7310 (18) 168
C45—H45⋯Cg1iii 0.95 2.90 3.7470 (18) 149

Symmetry codes: (i) Inline graphic; (ii) Inline graphic; (iii) Inline graphic.

Figure 4.

Figure 4

Part of the crystal structure of compound (I) showing the formation of a sheet lying parallel to (001) and built from C—H⋯O and C—H⋯π(arene) hydrogen bonds, which are drawn as dashed lines. For the sake of clarity, the H atoms bonded to the C atoms not involved in the motifs shown have been omitted.

Figure 5.

Figure 5

Part of the crystal structure of compound (I) showing the formation of a chain running parallel to [10Inline graphic] and built from C—H⋯π(arene) hydrogen bonds, which are drawn as dashed lines. For the sake of clarity, the H atoms not involved in the motifs shown have been omitted.

Figure 6.

Figure 6

Part of the crystal structure of compound (I) showing the two C—H⋯π(arene) hydrogen bonds with a common aryl acceptor. The hydrogen bonds are drawn as dashed lines and, for the sake of clarity, the unit-cell outline and the H atoms bonded to the C atoms not involved in the motifs shown have been omitted. The atoms marked with an asterisk (*) or a hash (#) are at the symmetry positions (Inline graphic + x, Inline graphic − y, −Inline graphic + z) and (Inline graphic − x, −Inline graphic + y, Inline graphic − z), respectively.

In contrast to the three-dimensional supra­molecular assembly in (I) generated by three hydrogen bonds, the only direction-specific inter­molecular inter­action in (II) is a single C—H⋯O contact, in which the D–-H⋯A angle is only 123° so that this cannot be regarded as structurally significant (Wood et al., 2009). The only direction-specific inter­molecular inter­actions in (III) are a C—Cl⋯(ring) contact involving the 1,3-dioxolane ring, but since this ring is not aromatic, this contact cannot be regarded as structurally significant; and a short Cl⋯Cl contact between inversion-related pairs of mol­ecules. For the atoms of type Cl44 in the mol­ecules at (x, y, z) and (−x, −y, 2 − z), the Cl⋯Cli distance is 3.3963 (7) Å with an associated C—Cl⋯Cli angle of 137.68 (5)° [symmetry code: (i) −x, −y, 2 − z]. For C—Cl⋯Cl angles of 90 and 180°, values of 1.78 and 1.58 Å have been suggested (Nyburg & Faerman, 1985) for the major and minor van der Waals radii: on this basis, a value of around 1.68 Å would seem appropriate to a C—Cl⋯Cl angle close to 135°, so that the observed Cl⋯Cl contact distance in (III) is not exceptional, and is probably therefore of no structural significance. Thus for both (II) and (III), the mol­ecular packing depends solely on mol­ecular shape and van der Waals forces.

Database survey  

It is of inter­est briefly to compare the supra­molecular assembly found here for compounds (I)–(III) with that observed in some related compounds. In 1-[(1,3-benzodioxol-5-yl)meth­yl]-4-(pyrimidin-2-yl)piperazine (piribedil), the mol­ecules are linked into sheets by three independent C—H⋯π hydrogen bonds (Wu et al., 2013), and in 1-(2-iodo­benzo­yl)-4-(pyrimidin-2-yl)piperazine, the mol­ecules are linked by a combination of C—H⋯O and C—H⋯π hydrogen bonds to form a three-dimensional structure which is augmented by π–π stacking inter­actions and N⋯I inter­actions (Mahesha et al., 2019). The amidic compound N-(4-chloro­phen­yl)-4-(pyrimidin-2-yl)piperazine-1-carboxamide crystallizes with Z′ = 2 in space group P21/c, and the mol­ecules are linked by two independent N—H⋯O hydrogen bonds to form chains of Inline graphic(8) type, although these are described as C(4) in the original report (Li, 2011). Finally, we note the structures of three salts derived by monoprotonation of the starting material 1-[(1,3-benzodioxol-5-yl)meth­yl]piperazine used in the synthesis of compounds (I)–(III): protonation occurs at the unsubstituted N atom of the piperazine unit in each of the picrate (Kavitha et al., 2014a ), 4-nitro­benzoate (Kavitha et al., 2014b ) and 4-chloro­benzoate (Kavitha et al., 2014c ) salts, although the schematic diagrams given for the two carboxyl­ate salts depict protonation at the substituted N atom.

Synthesis and crystallization  

1-[(1,3-Benzodioxol-5-yl)methyl]piperazine was purchased from Sigma–Aldrich and used as received. For the synthesis of compounds (I)–(III), 1-(3-di­methyl­amino­prop­yl)-3-ethyl­carbodimide (207 mg, 1.08 mmol), 1-hy­droxy­benzotriazole (121.6 mg, 0.9 mmol) and tri­ethyl­amine (0.5 ml, 3.7 mmol) were added to solutions of the appropriately substituted benzoic acid [3-fluoro­benzoic acid for (I), 2,6-di­fluoro­benzoic acid for (II) or 2,4-di­chloro­benzoic acid for (III)] (0.9 mmol) in N,N-di­methyl­formamide (5 ml) and the resulting mixtures were then stirred at 273 K for 20 min. A solution of 1-[(1,3-benzodioxol-5-yl)methyl]­piperazine (200 mg, 0.9 mmol) in N,N-di­methyl­formamide (5 ml) was then added to each mixture and stirring was continued overnight at ambient temperature. When the reactions were complete as confirmed using thin-layer chromatography, an excess of water was added to each of the mixtures, which were then exhaustively extracted using ethyl acetate. Each of the organic fractions was then washed successively with aqueous hydro­chloric acid (1 mol dm−3), then with a saturated aqueous solution of sodium hydrogencarbonate, and finally with brine. The organic fractions were then dried over anhydrous sodium sulfate and concentrated under reduced pressure. Slow evaporation of these solutions, at ambient temperature and in the presence of air, gave crystals of compounds (I)–(III) suitable for single-crystal X-ray diffraction: m.p. (I) 383–386 K, (II) 373 K, (III) 394–396 K.

Refinement  

Crystal data, data collection and structure refinement details are summarized in Table 2. All H atoms were located in difference maps, and they were subsequently treated as riding atoms in geometrically idealized positions with C—H distances 0.95 Å (aromatic) or 0.99 Å (CH2) and with U iso(H) = 1.2U eq(C). For compound (I), fifteen bad outlier reflections were omitted from the data set. For compound (II), the correct orientation of the structure with respect to the polar axis direction could not be established because of the lack of significant resonant scattering: thus calculation of the Flack x parameter (Flack, 1983) using using 1369 quotients of the type [(I +) − (I )]/[(I +) + (I )] (Parsons et al., 2013) gave a value −0.3 (10), which must be regarded as indeterminate (Flack & Bernardinelli, 2000), despite the 93% coverage of Friedel pairs, while the value of the Hooft y parameter (Hooft et al., 2008), y = −0.2 (6), is likewise indeterminate.

Supplementary Material

Crystal structure: contains datablock(s) global, I, II, III. DOI: 10.1107/S2056989019000458/zl2747sup1.cif

e-75-00202-sup1.cif (876.5KB, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989019000458/zl2747Isup2.hkl

e-75-00202-Isup2.hkl (293.2KB, hkl)

Structure factors: contains datablock(s) II. DOI: 10.1107/S2056989019000458/zl2747IIsup3.hkl

e-75-00202-IIsup3.hkl (298.6KB, hkl)

Structure factors: contains datablock(s) III. DOI: 10.1107/S2056989019000458/zl2747IIIsup4.hkl

e-75-00202-IIIsup4.hkl (323.2KB, hkl)

Supporting information file. DOI: 10.1107/S2056989019000458/zl2747Isup5.cml

Supporting information file. DOI: 10.1107/S2056989019000458/zl2747IIsup6.cml

Supporting information file. DOI: 10.1107/S2056989019000458/zl2747IIIsup7.cml

CCDC references: 1889708, 1889709, 1889710

Additional supporting information: crystallographic information; 3D view; checkCIF report

Acknowledgments

NM is grateful to the University of Mysore for research facilities.

supplementary crystallographic information

1-[(1,3-Benzodioxol-5-yl)methyl]-4-(3-fluorobenzoyl)piperazine (I). Crystal data

C19H19FN2O3 F(000) = 720
Mr = 342.36 Dx = 1.357 Mg m3
Monoclinic, P21/n Mo Kα radiation, λ = 0.71073 Å
a = 12.2358 (16) Å Cell parameters from 3689 reflections
b = 10.3185 (14) Å θ = 1.9–27.6°
c = 14.2310 (19) Å µ = 0.10 mm1
β = 111.199 (2)° T = 173 K
V = 1675.2 (4) Å3 Block, colourless
Z = 4 0.48 × 0.29 × 0.28 mm

1-[(1,3-Benzodioxol-5-yl)methyl]-4-(3-fluorobenzoyl)piperazine (I). Data collection

Bruker APEXII CCD diffractometer 3674 independent reflections
Radiation source: fine focus sealed tube 2975 reflections with I > 2σ(I)
Graphite monochromator Rint = 0.021
Detector resolution: 0.3333 pixels mm-1 θmax = 27.6°, θmin = 1.9°
φ and ω scans h = −10→15
Absorption correction: multi-scan (SADABS; Bruker, 2015) k = −13→13
Tmin = 0.813, Tmax = 0.972 l = −18→9
8635 measured reflections

1-[(1,3-Benzodioxol-5-yl)methyl]-4-(3-fluorobenzoyl)piperazine (I). Refinement

Refinement on F2 0 restraints
Least-squares matrix: full Hydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.040 H-atom parameters constrained
wR(F2) = 0.114 w = 1/[σ2(Fo2) + (0.0476P)2 + 0.4713P] where P = (Fo2 + 2Fc2)/3
S = 1.10 (Δ/σ)max < 0.001
3674 reflections Δρmax = 0.24 e Å3
226 parameters Δρmin = −0.18 e Å3

1-[(1,3-Benzodioxol-5-yl)methyl]-4-(3-fluorobenzoyl)piperazine (I). Special details

Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.

1-[(1,3-Benzodioxol-5-yl)methyl]-4-(3-fluorobenzoyl)piperazine (I). Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)

x y z Uiso*/Ueq
N1 0.57212 (10) 0.47476 (11) 0.26954 (9) 0.0303 (3)
C2 0.51223 (13) 0.44782 (14) 0.33984 (11) 0.0330 (3)
H2A 0.5622 0.3918 0.3952 0.040*
H2B 0.4379 0.4014 0.3043 0.040*
C3 0.48694 (13) 0.57400 (15) 0.38272 (11) 0.0356 (3)
H3A 0.4438 0.5560 0.4283 0.043*
H3B 0.5616 0.6173 0.4224 0.043*
N4 0.41697 (11) 0.65903 (12) 0.30093 (9) 0.0327 (3)
C5 0.47088 (13) 0.68273 (14) 0.22552 (11) 0.0327 (3)
H5A 0.5444 0.7325 0.2564 0.039*
H5B 0.4170 0.7344 0.1691 0.039*
C6 0.49704 (13) 0.55452 (14) 0.18609 (11) 0.0313 (3)
H6A 0.4228 0.5081 0.1502 0.038*
H6B 0.5368 0.5704 0.1377 0.038*
C11 0.60711 (14) 0.35498 (14) 0.23287 (12) 0.0368 (3)
H11A 0.5367 0.3124 0.1845 0.044*
H11B 0.6424 0.2951 0.2903 0.044*
O11 0.95161 (10) 0.44449 (12) 0.06543 (9) 0.0460 (3)
C12 1.01387 (15) 0.54464 (18) 0.13322 (13) 0.0450 (4)
H12A 1.0984 0.5232 0.1624 0.054*
H12B 1.0049 0.6279 0.0967 0.054*
O13 0.96722 (10) 0.55552 (12) 0.21141 (9) 0.0453 (3)
C3A 0.86787 (13) 0.48056 (14) 0.18111 (11) 0.0317 (3)
C14 0.78769 (13) 0.46591 (14) 0.22718 (11) 0.0323 (3)
H14 0.7950 0.5118 0.2870 0.039*
C15 0.69410 (13) 0.37999 (14) 0.18201 (11) 0.0327 (3)
C16 0.68486 (14) 0.31574 (15) 0.09369 (12) 0.0384 (4)
H16 0.6203 0.2592 0.0636 0.046*
C17 0.76762 (14) 0.33156 (16) 0.04750 (12) 0.0399 (4)
H17 0.7610 0.2869 −0.0127 0.048*
C7A 0.85801 (14) 0.41432 (14) 0.09347 (11) 0.0347 (3)
C47 0.32103 (13) 0.72461 (14) 0.29797 (11) 0.0328 (3)
O47 0.27475 (12) 0.80626 (13) 0.23290 (10) 0.0583 (4)
C41 0.26784 (12) 0.69823 (13) 0.37650 (11) 0.0291 (3)
C42 0.22151 (13) 0.57722 (14) 0.38544 (11) 0.0333 (3)
H42 0.2306 0.5049 0.3476 0.040*
C43 0.16209 (14) 0.56607 (15) 0.45098 (12) 0.0367 (3)
F43 0.11374 (10) 0.44972 (10) 0.45775 (9) 0.0590 (3)
C44 0.14867 (13) 0.66616 (16) 0.50952 (12) 0.0377 (4)
H44 0.1079 0.6542 0.5544 0.045*
C45 0.19660 (13) 0.78531 (16) 0.50088 (12) 0.0381 (4)
H45 0.1896 0.8563 0.5409 0.046*
C46 0.25459 (13) 0.80141 (14) 0.43428 (12) 0.0345 (3)
H46 0.2857 0.8839 0.4280 0.041*

1-[(1,3-Benzodioxol-5-yl)methyl]-4-(3-fluorobenzoyl)piperazine (I). Atomic displacement parameters (Å2)

U11 U22 U33 U12 U13 U23
N1 0.0328 (6) 0.0277 (6) 0.0323 (6) 0.0018 (5) 0.0140 (5) 0.0033 (5)
C2 0.0307 (7) 0.0341 (8) 0.0338 (8) 0.0021 (6) 0.0113 (6) 0.0106 (6)
C3 0.0349 (8) 0.0444 (9) 0.0275 (7) 0.0076 (6) 0.0114 (6) 0.0080 (6)
N4 0.0373 (7) 0.0345 (7) 0.0283 (6) 0.0068 (5) 0.0145 (5) 0.0068 (5)
C5 0.0388 (8) 0.0300 (7) 0.0317 (7) 0.0015 (6) 0.0157 (6) 0.0061 (6)
C6 0.0350 (8) 0.0311 (7) 0.0285 (7) −0.0005 (6) 0.0121 (6) 0.0025 (6)
C11 0.0408 (8) 0.0276 (7) 0.0427 (9) 0.0007 (6) 0.0160 (7) 0.0009 (6)
O11 0.0512 (7) 0.0504 (7) 0.0447 (7) −0.0015 (5) 0.0275 (6) −0.0093 (5)
C12 0.0400 (9) 0.0524 (10) 0.0469 (10) 0.0013 (7) 0.0209 (8) −0.0054 (8)
O13 0.0426 (6) 0.0511 (7) 0.0478 (7) −0.0086 (5) 0.0231 (6) −0.0146 (5)
C3A 0.0325 (7) 0.0279 (7) 0.0318 (7) 0.0059 (6) 0.0082 (6) −0.0006 (6)
C14 0.0367 (8) 0.0306 (7) 0.0290 (7) 0.0048 (6) 0.0113 (6) −0.0022 (6)
C15 0.0351 (8) 0.0273 (7) 0.0344 (8) 0.0064 (6) 0.0108 (6) 0.0013 (6)
C16 0.0358 (8) 0.0344 (8) 0.0391 (8) 0.0030 (6) 0.0066 (7) −0.0068 (6)
C17 0.0465 (9) 0.0388 (8) 0.0324 (8) 0.0077 (7) 0.0117 (7) −0.0073 (6)
C7A 0.0401 (8) 0.0330 (8) 0.0330 (8) 0.0109 (6) 0.0160 (7) 0.0023 (6)
C47 0.0369 (8) 0.0260 (7) 0.0370 (8) 0.0018 (6) 0.0150 (6) 0.0059 (6)
O47 0.0624 (8) 0.0576 (8) 0.0686 (9) 0.0303 (6) 0.0401 (7) 0.0385 (7)
C41 0.0263 (7) 0.0280 (7) 0.0303 (7) 0.0019 (5) 0.0071 (6) 0.0036 (5)
C42 0.0400 (8) 0.0268 (7) 0.0329 (7) −0.0001 (6) 0.0128 (7) 0.0002 (6)
C43 0.0383 (8) 0.0311 (8) 0.0398 (8) −0.0047 (6) 0.0130 (7) 0.0068 (6)
F43 0.0759 (8) 0.0378 (6) 0.0757 (7) −0.0142 (5) 0.0424 (6) 0.0061 (5)
C44 0.0342 (8) 0.0466 (9) 0.0337 (8) 0.0027 (7) 0.0141 (7) 0.0058 (7)
C45 0.0368 (8) 0.0382 (8) 0.0387 (8) 0.0020 (6) 0.0127 (7) −0.0064 (7)
C46 0.0332 (8) 0.0270 (7) 0.0431 (8) −0.0020 (6) 0.0135 (7) −0.0006 (6)

1-[(1,3-Benzodioxol-5-yl)methyl]-4-(3-fluorobenzoyl)piperazine (I). Geometric parameters (Å, º)

N1—C6 1.4638 (18) O13—C3A 1.3722 (18)
N1—C11 1.4645 (18) C3A—C14 1.371 (2)
N1—C2 1.4647 (18) C3A—C7A 1.389 (2)
C2—C3 1.517 (2) C14—C15 1.406 (2)
C2—H2A 0.9900 C14—H14 0.9500
C2—H2B 0.9900 C15—C16 1.389 (2)
C3—N4 1.4619 (18) C16—C17 1.402 (2)
C3—H3A 0.9900 C16—H16 0.9500
C3—H3B 0.9900 C17—C7A 1.363 (2)
N4—C47 1.3423 (19) C17—H17 0.9500
N4—C5 1.4692 (17) C47—O47 1.2283 (18)
C5—C6 1.5156 (19) C47—C41 1.507 (2)
C5—H5A 0.9900 C41—C46 1.390 (2)
C5—H5B 0.9900 C41—C42 1.3960 (19)
C6—H6A 0.9900 C42—C43 1.379 (2)
C6—H6B 0.9900 C42—H42 0.9500
C11—C15 1.510 (2) C43—F43 1.3572 (17)
C11—H11A 0.9900 C43—C44 1.374 (2)
C11—H11B 0.9900 C44—C45 1.387 (2)
O11—C7A 1.3777 (19) C44—H44 0.9500
O11—C12 1.431 (2) C45—C46 1.384 (2)
C12—O13 1.4268 (19) C45—H45 0.9500
C12—H12A 0.9900 C46—H46 0.9500
C12—H12B 0.9900
C6—N1—C11 111.35 (11) H12A—C12—H12B 108.4
C6—N1—C2 109.80 (11) C3A—O13—C12 105.63 (12)
C11—N1—C2 111.48 (11) C14—C3A—O13 128.14 (13)
N1—C2—C3 109.70 (12) C14—C3A—C7A 122.03 (14)
N1—C2—H2A 109.7 O13—C3A—C7A 109.82 (13)
C3—C2—H2A 109.7 C3A—C14—C15 117.14 (13)
N1—C2—H2B 109.7 C3A—C14—H14 121.4
C3—C2—H2B 109.7 C15—C14—H14 121.4
H2A—C2—H2B 108.2 C16—C15—C14 120.05 (14)
N4—C3—C2 109.93 (12) C16—C15—C11 120.75 (14)
N4—C3—H3A 109.7 C14—C15—C11 119.16 (13)
C2—C3—H3A 109.7 C15—C16—C17 122.17 (15)
N4—C3—H3B 109.7 C15—C16—H16 118.9
C2—C3—H3B 109.7 C17—C16—H16 118.9
H3A—C3—H3B 108.2 C7A—C17—C16 116.51 (14)
C47—N4—C3 125.54 (12) C7A—C17—H17 121.7
C47—N4—C5 120.78 (12) C16—C17—H17 121.7
C3—N4—C5 113.15 (11) C17—C7A—O11 128.17 (14)
N4—C5—C6 109.62 (11) C17—C7A—C3A 122.10 (14)
N4—C5—H5A 109.7 O11—C7A—C3A 109.73 (14)
C6—C5—H5A 109.7 O47—C47—N4 121.94 (13)
N4—C5—H5B 109.7 O47—C47—C41 118.54 (13)
C6—C5—H5B 109.7 N4—C47—C41 119.52 (12)
H5A—C5—H5B 108.2 C46—C41—C42 119.54 (13)
N1—C6—C5 110.19 (12) C46—C41—C47 118.31 (12)
N1—C6—H6A 109.6 C42—C41—C47 121.84 (13)
C5—C6—H6A 109.6 C43—C42—C41 117.84 (13)
N1—C6—H6B 109.6 C43—C42—H42 121.1
C5—C6—H6B 109.6 C41—C42—H42 121.1
H6A—C6—H6B 108.1 F43—C43—C44 118.11 (14)
N1—C11—C15 111.97 (12) F43—C43—C42 118.15 (14)
N1—C11—H11A 109.2 C44—C43—C42 123.73 (14)
C15—C11—H11A 109.2 C43—C44—C45 117.76 (14)
N1—C11—H11B 109.2 C43—C44—H44 121.1
C15—C11—H11B 109.2 C45—C44—H44 121.1
H11A—C11—H11B 107.9 C46—C45—C44 120.34 (14)
C7A—O11—C12 105.29 (11) C46—C45—H45 119.8
O13—C12—O11 108.48 (13) C44—C45—H45 119.8
O13—C12—H12A 110.0 C45—C46—C41 120.77 (14)
O11—C12—H12A 110.0 C45—C46—H46 119.6
O13—C12—H12B 110.0 C41—C46—H46 119.6
O11—C12—H12B 110.0
C6—N1—C2—C3 −60.96 (15) C16—C17—C7A—C3A −0.4 (2)
C11—N1—C2—C3 175.17 (12) C12—O11—C7A—C17 174.64 (16)
N1—C2—C3—N4 57.23 (15) C12—O11—C7A—C3A −6.53 (16)
C2—C3—N4—C47 133.38 (15) C14—C3A—C7A—C17 0.5 (2)
C2—C3—N4—C5 −55.00 (16) O13—C3A—C7A—C17 179.30 (14)
C47—N4—C5—C6 −133.39 (14) C14—C3A—C7A—O11 −178.38 (13)
C3—N4—C5—C6 54.54 (16) O13—C3A—C7A—O11 0.39 (17)
C11—N1—C6—C5 −175.10 (11) C3—N4—C47—O47 171.03 (16)
C2—N1—C6—C5 60.95 (15) C5—N4—C47—O47 0.0 (2)
N4—C5—C6—N1 −56.63 (15) C3—N4—C47—C41 −8.9 (2)
C6—N1—C11—C15 71.31 (15) C5—N4—C47—C41 −179.92 (13)
C2—N1—C11—C15 −165.70 (12) O47—C47—C41—C46 −56.5 (2)
C7A—O11—C12—O13 10.19 (17) N4—C47—C41—C46 123.39 (16)
O11—C12—O13—C3A −9.99 (17) O47—C47—C41—C42 116.97 (17)
C12—O13—C3A—C14 −175.37 (15) N4—C47—C41—C42 −63.11 (19)
C12—O13—C3A—C7A 5.95 (17) C46—C41—C42—C43 1.1 (2)
O13—C3A—C14—C15 −178.36 (14) C47—C41—C42—C43 −172.33 (13)
C7A—C3A—C14—C15 0.2 (2) C41—C42—C43—F43 178.02 (14)
C3A—C14—C15—C16 −0.9 (2) C41—C42—C43—C44 −1.7 (2)
C3A—C14—C15—C11 176.73 (13) F43—C43—C44—C45 −178.92 (14)
N1—C11—C15—C16 −138.33 (14) C42—C43—C44—C45 0.8 (2)
N1—C11—C15—C14 44.02 (18) C43—C44—C45—C46 0.7 (2)
C14—C15—C16—C17 1.1 (2) C44—C45—C46—C41 −1.3 (2)
C11—C15—C16—C17 −176.55 (14) C42—C41—C46—C45 0.4 (2)
C15—C16—C17—C7A −0.4 (2) C47—C41—C46—C45 174.01 (13)
C16—C17—C7A—O11 178.28 (14)

1-[(1,3-Benzodioxol-5-yl)methyl]-4-(3-fluorobenzoyl)piperazine (I). Hydrogen-bond geometry (Å, º)

Cg1 represents the centroid of the C3A, C14, C15, C16, C17, C7A ring.

D—H···A D—H H···A D···A D—H···A
C42—H42···O47i 0.95 2.34 3.273 (2) 168
C5—H5A···Cg1ii 0.99 2.76 3.7310 (18) 168
C45—H45···Cg1iii 0.95 2.90 3.7470 (18) 149

Symmetry codes: (i) −x+1/2, y−1/2, −z+1/2; (ii) −x+3/2, y+1/2, −z+1/2; (iii) x−1/2, −y+3/2, z+1/2.

1-[(1,3-Benzodioxol-5-yl)methyl]-4-(2,6-difluorobenzoyl)piperazine (II). Crystal data

C19H18F2N2O3 Dx = 1.422 Mg m3
Mr = 360.35 Mo Kα radiation, λ = 0.71073 Å
Orthorhombic, Pca21 Cell parameters from 3743 reflections
a = 14.2762 (9) Å θ = 1.9–27.5°
b = 15.9821 (10) Å µ = 0.11 mm1
c = 7.3753 (5) Å T = 173 K
V = 1682.78 (19) Å3 Needle, colourless
Z = 4 0.91 × 0.35 × 0.17 mm
F(000) = 752

1-[(1,3-Benzodioxol-5-yl)methyl]-4-(2,6-difluorobenzoyl)piperazine (II). Data collection

Bruker APEXII CCD diffractometer 3743 independent reflections
Radiation source: fine focus sealed tube 3449 reflections with I > 2σ(I)
Graphite monochromator Rint = 0.057
Detector resolution: 0.3333 pixels mm-1 θmax = 27.5°, θmin = 1.9°
φ and ω scans h = −14→18
Absorption correction: multi-scan (SADABS; Bruker, 2015) k = −16→20
Tmin = 0.587, Tmax = 0.981 l = −9→9
9016 measured reflections

1-[(1,3-Benzodioxol-5-yl)methyl]-4-(2,6-difluorobenzoyl)piperazine (II). Refinement

Refinement on F2 Hydrogen site location: inferred from neighbouring sites
Least-squares matrix: full H-atom parameters constrained
R[F2 > 2σ(F2)] = 0.054 w = 1/[σ2(Fo2) + (0.096P)2] where P = (Fo2 + 2Fc2)/3
wR(F2) = 0.155 (Δ/σ)max < 0.001
S = 1.16 Δρmax = 0.17 e Å3
3743 reflections Δρmin = −0.21 e Å3
235 parameters Absolute structure: Flack x determined using 1369 quotients [(I+)-(I-)]/[(I+)+(I-)] (Parsons et al., 2013)
1 restraint

1-[(1,3-Benzodioxol-5-yl)methyl]-4-(2,6-difluorobenzoyl)piperazine (II). Special details

Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.

1-[(1,3-Benzodioxol-5-yl)methyl]-4-(2,6-difluorobenzoyl)piperazine (II). Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)

x y z Uiso*/Ueq
N1 0.36051 (17) 0.62727 (15) 0.3017 (3) 0.0249 (5)
C2 0.3856 (2) 0.71107 (18) 0.2369 (5) 0.0302 (6)
H2A 0.3597 0.7197 0.1138 0.036*
H2B 0.4546 0.7163 0.2299 0.036*
C3 0.3470 (2) 0.77682 (17) 0.3641 (4) 0.0302 (6)
H3A 0.3686 0.8328 0.3249 0.036*
H3B 0.2777 0.7762 0.3590 0.036*
N4 0.37766 (17) 0.76146 (14) 0.5509 (4) 0.0265 (5)
C5 0.3658 (2) 0.67513 (15) 0.6138 (4) 0.0247 (5)
H5A 0.2984 0.6633 0.6317 0.030*
H5B 0.3979 0.6679 0.7317 0.030*
C6 0.40582 (18) 0.61456 (18) 0.4776 (4) 0.0243 (6)
H6A 0.4742 0.6236 0.4659 0.029*
H6B 0.3953 0.5564 0.5193 0.029*
C11 0.3880 (2) 0.5620 (2) 0.1720 (4) 0.0320 (7)
H11A 0.4569 0.5628 0.1566 0.038*
H11B 0.3592 0.5740 0.0526 0.038*
O11 0.26117 (18) 0.25056 (13) 0.4272 (4) 0.0445 (6)
C12 0.1638 (3) 0.2617 (2) 0.3896 (6) 0.0426 (8)
H12A 0.1431 0.2208 0.2971 0.051*
H12B 0.1266 0.2526 0.5011 0.051*
O13 0.15012 (16) 0.34454 (15) 0.3247 (4) 0.0436 (6)
C3A 0.2382 (2) 0.37818 (18) 0.3049 (5) 0.0295 (6)
C14 0.2621 (2) 0.45542 (17) 0.2400 (4) 0.0299 (6)
H14 0.2157 0.4937 0.1993 0.036*
C15 0.35761 (19) 0.47614 (18) 0.2356 (4) 0.0276 (6)
C16 0.4231 (2) 0.4189 (2) 0.2983 (4) 0.0309 (6)
H16 0.4875 0.4339 0.2961 0.037*
C17 0.3983 (2) 0.34019 (19) 0.3646 (5) 0.0336 (7)
H17 0.4438 0.3015 0.4067 0.040*
C7A 0.3045 (2) 0.32183 (18) 0.3656 (4) 0.0317 (6)
C47 0.4015 (2) 0.82057 (17) 0.6718 (4) 0.0262 (6)
O47 0.41835 (17) 0.80559 (13) 0.8317 (3) 0.0366 (5)
C41 0.4064 (2) 0.91022 (16) 0.6064 (5) 0.0277 (6)
C42 0.3281 (2) 0.96071 (19) 0.5945 (6) 0.0384 (8)
F42 0.24359 (14) 0.92331 (12) 0.6222 (4) 0.0620 (8)
C43 0.3316 (3) 1.0447 (2) 0.5555 (7) 0.0476 (9)
H43 0.2760 1.0772 0.5492 0.057*
C44 0.4181 (3) 1.0804 (2) 0.5258 (5) 0.0432 (9)
H44 0.4221 1.1383 0.4980 0.052*
C45 0.4992 (2) 1.03346 (19) 0.5357 (5) 0.0375 (8)
H45 0.5587 1.0584 0.5158 0.045*
C46 0.4913 (2) 0.94955 (18) 0.5754 (5) 0.0303 (6)
F46 0.56966 (12) 0.90206 (13) 0.5843 (4) 0.0464 (6)

1-[(1,3-Benzodioxol-5-yl)methyl]-4-(2,6-difluorobenzoyl)piperazine (II). Atomic displacement parameters (Å2)

U11 U22 U33 U12 U13 U23
N1 0.0308 (11) 0.0227 (11) 0.0214 (11) −0.0015 (9) −0.0005 (9) 0.0023 (9)
C2 0.0356 (14) 0.0296 (15) 0.0254 (14) −0.0041 (12) −0.0029 (12) 0.0090 (13)
C3 0.0399 (14) 0.0214 (12) 0.0293 (16) −0.0025 (11) −0.0088 (12) 0.0068 (12)
N4 0.0347 (11) 0.0173 (10) 0.0274 (13) −0.0015 (9) −0.0039 (10) 0.0052 (9)
C5 0.0328 (12) 0.0169 (11) 0.0243 (13) −0.0024 (10) −0.0002 (11) 0.0029 (11)
C6 0.0267 (12) 0.0220 (13) 0.0241 (14) 0.0012 (10) 0.0000 (11) 0.0044 (11)
C11 0.0400 (15) 0.0328 (15) 0.0232 (14) 0.0002 (13) 0.0051 (12) −0.0003 (12)
O11 0.0469 (14) 0.0305 (11) 0.0563 (17) 0.0005 (10) −0.0008 (12) 0.0081 (11)
C12 0.0465 (19) 0.0387 (17) 0.043 (2) −0.0081 (14) −0.0024 (15) −0.0013 (15)
O13 0.0332 (11) 0.0427 (13) 0.0547 (16) −0.0046 (10) −0.0009 (11) 0.0050 (12)
C3A 0.0282 (13) 0.0343 (14) 0.0260 (14) 0.0040 (12) −0.0012 (11) −0.0043 (12)
C14 0.0338 (13) 0.0308 (13) 0.0252 (14) 0.0072 (12) −0.0048 (12) −0.0008 (13)
C15 0.0371 (14) 0.0266 (13) 0.0191 (12) 0.0031 (11) 0.0018 (11) −0.0044 (11)
C16 0.0283 (12) 0.0336 (16) 0.0307 (15) 0.0059 (11) 0.0018 (12) −0.0063 (13)
C17 0.0374 (14) 0.0270 (14) 0.0365 (17) 0.0093 (12) −0.0025 (13) −0.0011 (13)
C7A 0.0420 (15) 0.0242 (13) 0.0289 (16) 0.0036 (12) 0.0004 (13) −0.0027 (12)
C47 0.0293 (11) 0.0188 (12) 0.0304 (15) −0.0014 (10) −0.0014 (11) 0.0043 (11)
O47 0.0560 (13) 0.0233 (10) 0.0305 (13) −0.0055 (9) −0.0064 (10) 0.0021 (9)
C41 0.0365 (14) 0.0183 (12) 0.0284 (15) −0.0031 (11) −0.0002 (12) 0.0023 (11)
C42 0.0344 (14) 0.0295 (16) 0.051 (2) −0.0016 (12) 0.0038 (14) 0.0095 (15)
F42 0.0323 (9) 0.0451 (11) 0.109 (2) −0.0006 (10) 0.0056 (12) 0.0293 (14)
C43 0.0502 (19) 0.0283 (16) 0.064 (3) 0.0091 (14) 0.0094 (18) 0.0128 (16)
C44 0.068 (2) 0.0187 (14) 0.043 (2) −0.0038 (14) 0.0079 (17) 0.0061 (13)
C45 0.0461 (17) 0.0282 (14) 0.038 (2) −0.0127 (14) 0.0074 (13) 0.0019 (14)
C46 0.0331 (14) 0.0265 (13) 0.0313 (17) −0.0021 (11) 0.0026 (12) 0.0003 (13)
F46 0.0330 (9) 0.0404 (11) 0.0658 (16) 0.0006 (8) 0.0054 (10) 0.0060 (11)

1-[(1,3-Benzodioxol-5-yl)methyl]-4-(2,6-difluorobenzoyl)piperazine (II). Geometric parameters (Å, º)

N1—C6 1.464 (4) O13—C3A 1.375 (4)
N1—C2 1.466 (3) C3A—C14 1.367 (4)
N1—C11 1.469 (4) C3A—C7A 1.381 (4)
C2—C3 1.513 (4) C14—C15 1.404 (4)
C2—H2A 0.9900 C14—H14 0.9500
C2—H2B 0.9900 C15—C16 1.388 (4)
C3—N4 1.466 (4) C16—C17 1.395 (5)
C3—H3A 0.9900 C16—H16 0.9500
C3—H3B 0.9900 C17—C7A 1.370 (4)
N4—C47 1.343 (4) C17—H17 0.9500
N4—C5 1.465 (3) C47—O47 1.227 (4)
C5—C6 1.507 (4) C47—C41 1.513 (4)
C5—H5A 0.9900 C41—C42 1.382 (4)
C5—H5B 0.9900 C41—C46 1.384 (4)
C6—H6A 0.9900 C42—F42 1.362 (3)
C6—H6B 0.9900 C42—C43 1.373 (4)
C11—C15 1.514 (4) C43—C44 1.379 (5)
C11—H11A 0.9900 C43—H43 0.9500
C11—H11B 0.9900 C44—C45 1.381 (5)
O11—C7A 1.374 (4) C44—H44 0.9500
O11—C12 1.429 (4) C45—C46 1.377 (4)
C12—O13 1.422 (4) C45—H45 0.9500
C12—H12A 0.9900 C46—F46 1.354 (3)
C12—H12B 0.9900
C6—N1—C2 107.9 (2) H12A—C12—H12B 108.4
C6—N1—C11 111.2 (2) C3A—O13—C12 105.9 (2)
C2—N1—C11 111.8 (2) C14—C3A—O13 128.2 (3)
N1—C2—C3 110.1 (3) C14—C3A—C7A 122.1 (3)
N1—C2—H2A 109.6 O13—C3A—C7A 109.7 (3)
C3—C2—H2A 109.6 C3A—C14—C15 117.6 (3)
N1—C2—H2B 109.6 C3A—C14—H14 121.2
C3—C2—H2B 109.6 C15—C14—H14 121.2
H2A—C2—H2B 108.2 C16—C15—C14 119.4 (3)
N4—C3—C2 111.0 (2) C16—C15—C11 120.5 (3)
N4—C3—H3A 109.4 C14—C15—C11 120.0 (3)
C2—C3—H3A 109.4 C15—C16—C17 122.6 (3)
N4—C3—H3B 109.4 C15—C16—H16 118.7
C2—C3—H3B 109.4 C17—C16—H16 118.7
H3A—C3—H3B 108.0 C7A—C17—C16 116.3 (3)
C47—N4—C5 118.8 (3) C7A—C17—H17 121.8
C47—N4—C3 125.6 (2) C16—C17—H17 121.8
C5—N4—C3 114.9 (2) C17—C7A—O11 128.3 (3)
N4—C5—C6 110.5 (2) C17—C7A—C3A 121.9 (3)
N4—C5—H5A 109.6 O11—C7A—C3A 109.8 (3)
C6—C5—H5A 109.6 O47—C47—N4 123.4 (3)
N4—C5—H5B 109.6 O47—C47—C41 118.8 (3)
C6—C5—H5B 109.6 N4—C47—C41 117.8 (3)
H5A—C5—H5B 108.1 C42—C41—C46 115.6 (2)
N1—C6—C5 109.5 (2) C42—C41—C47 122.4 (2)
N1—C6—H6A 109.8 C46—C41—C47 121.6 (3)
C5—C6—H6A 109.8 F42—C42—C43 119.5 (3)
N1—C6—H6B 109.8 F42—C42—C41 116.8 (2)
C5—C6—H6B 109.8 C43—C42—C41 123.7 (3)
H6A—C6—H6B 108.2 C42—C43—C44 118.0 (3)
N1—C11—C15 111.4 (2) C42—C43—H43 121.0
N1—C11—H11A 109.3 C44—C43—H43 121.0
C15—C11—H11A 109.3 C43—C44—C45 121.2 (3)
N1—C11—H11B 109.3 C43—C44—H44 119.4
C15—C11—H11B 109.3 C45—C44—H44 119.4
H11A—C11—H11B 108.0 C46—C45—C44 118.1 (3)
C7A—O11—C12 105.7 (2) C46—C45—H45 120.9
O13—C12—O11 108.4 (3) C44—C45—H45 120.9
O13—C12—H12A 110.0 F46—C46—C45 119.2 (3)
O11—C12—H12A 110.0 F46—C46—C41 117.4 (2)
O13—C12—H12B 110.0 C45—C46—C41 123.3 (3)
O11—C12—H12B 110.0
C6—N1—C2—C3 −63.5 (3) C12—O11—C7A—C3A 4.4 (4)
C11—N1—C2—C3 173.9 (2) C14—C3A—C7A—C17 0.1 (5)
N1—C2—C3—N4 54.5 (3) O13—C3A—C7A—C17 −178.7 (3)
C2—C3—N4—C47 142.2 (3) C14—C3A—C7A—O11 178.5 (3)
C2—C3—N4—C5 −48.1 (3) O13—C3A—C7A—O11 −0.4 (4)
C47—N4—C5—C6 −140.1 (3) C5—N4—C47—O47 3.6 (4)
C3—N4—C5—C6 49.5 (3) C3—N4—C47—O47 173.0 (3)
C2—N1—C6—C5 65.0 (3) C5—N4—C47—C41 −175.7 (2)
C11—N1—C6—C5 −172.1 (2) C3—N4—C47—C41 −6.3 (4)
N4—C5—C6—N1 −57.3 (3) O47—C47—C41—C42 −95.9 (4)
C6—N1—C11—C15 62.1 (3) N4—C47—C41—C42 83.4 (4)
C2—N1—C11—C15 −177.2 (2) O47—C47—C41—C46 76.3 (4)
C7A—O11—C12—O13 −6.7 (4) N4—C47—C41—C46 −104.4 (4)
O11—C12—O13—C3A 6.5 (4) C46—C41—C42—F42 179.2 (3)
C12—O13—C3A—C14 177.4 (3) C47—C41—C42—F42 −8.2 (5)
C12—O13—C3A—C7A −3.9 (4) C46—C41—C42—C43 −0.2 (6)
O13—C3A—C14—C15 179.0 (3) C47—C41—C42—C43 172.4 (4)
C7A—C3A—C14—C15 0.4 (5) F42—C42—C43—C44 −179.1 (4)
C3A—C14—C15—C16 −0.8 (4) C41—C42—C43—C44 0.3 (7)
C3A—C14—C15—C11 −177.6 (3) C42—C43—C44—C45 −0.3 (7)
N1—C11—C15—C16 −107.8 (3) C43—C44—C45—C46 0.3 (6)
N1—C11—C15—C14 69.0 (4) C44—C45—C46—F46 179.4 (3)
C14—C15—C16—C17 0.8 (5) C44—C45—C46—C41 −0.3 (5)
C11—C15—C16—C17 177.6 (3) C42—C41—C46—F46 −179.5 (3)
C15—C16—C17—C7A −0.3 (5) C47—C41—C46—F46 7.8 (5)
C16—C17—C7A—O11 −178.2 (3) C42—C41—C46—C45 0.3 (5)
C16—C17—C7A—C3A −0.2 (5) C47—C41—C46—C45 −172.4 (3)
C12—O11—C7A—C17 −177.4 (4)

1-[(1,3-Benzodioxol-5-yl)methyl]-4-(2,6-difluorobenzoyl)piperazine (II). Hydrogen-bond geometry (Å, º)

D—H···A D—H H···A D···A D—H···A
C45—H45···O47i 0.95 2.58 3.204 (4) 123

Symmetry code: (i) −x+1, −y+2, z−1/2.

1-[(1,3-Benzodioxol-5-yl)methyl]-4-(2,4-dichlorobenzoyl)piperazine (III). Crystal data

C19H18Cl2N2O3 F(000) = 816
Mr = 393.25 Dx = 1.442 Mg m3
Monoclinic, P21/n Mo Kα radiation, λ = 0.71073 Å
a = 12.2889 (14) Å Cell parameters from 4054 reflections
b = 12.3034 (14) Å θ = 2.4–27.4°
c = 13.3667 (15) Å µ = 0.38 mm1
β = 116.295 (1)° T = 173 K
V = 1811.9 (4) Å3 Block, colourless
Z = 4 0.49 × 0.48 × 0.38 mm

1-[(1,3-Benzodioxol-5-yl)methyl]-4-(2,4-dichlorobenzoyl)piperazine (III). Data collection

Bruker APEXII CCD diffractometer 4054 independent reflections
Radiation source: fine focus sealed tube 3545 reflections with I > 2σ(I)
Graphite monochromator Rint = 0.017
Detector resolution: 0.3333 pixels mm-1 θmax = 27.4°, θmin = 2.4°
φ and ω scans h = −15→11
Absorption correction: multi-scan (SADABS; Bruker, 2015) k = −15→15
Tmin = 0.776, Tmax = 0.867 l = −17→17
9718 measured reflections

1-[(1,3-Benzodioxol-5-yl)methyl]-4-(2,4-dichlorobenzoyl)piperazine (III). Refinement

Refinement on F2 0 restraints
Least-squares matrix: full Hydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.031 H-atom parameters constrained
wR(F2) = 0.087 w = 1/[σ2(Fo2) + (0.043P)2 + 0.6034P] where P = (Fo2 + 2Fc2)/3
S = 1.04 (Δ/σ)max = 0.001
4054 reflections Δρmax = 0.37 e Å3
235 parameters Δρmin = −0.37 e Å3

1-[(1,3-Benzodioxol-5-yl)methyl]-4-(2,4-dichlorobenzoyl)piperazine (III). Special details

Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.

1-[(1,3-Benzodioxol-5-yl)methyl]-4-(2,4-dichlorobenzoyl)piperazine (III). Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)

x y z Uiso*/Ueq
N1 0.52986 (10) 0.18706 (10) 0.64831 (10) 0.0293 (3)
C2 0.48214 (12) 0.13857 (13) 0.72047 (12) 0.0335 (3)
H2A 0.5451 0.1407 0.7989 0.040*
H2B 0.4609 0.0616 0.6993 0.040*
C3 0.37079 (12) 0.19934 (13) 0.71033 (11) 0.0321 (3)
H3A 0.3360 0.1622 0.7553 0.038*
H3B 0.3939 0.2740 0.7398 0.038*
N4 0.27950 (10) 0.20437 (11) 0.59349 (9) 0.0310 (3)
C5 0.32597 (13) 0.24338 (15) 0.51615 (12) 0.0376 (3)
H5A 0.3457 0.3217 0.5292 0.045*
H5B 0.2629 0.2343 0.4384 0.045*
C6 0.43884 (13) 0.18029 (13) 0.53272 (12) 0.0342 (3)
H6A 0.4173 0.1032 0.5122 0.041*
H6B 0.4723 0.2103 0.4834 0.041*
C11 0.64509 (13) 0.13691 (12) 0.66549 (15) 0.0371 (3)
H11A 0.6295 0.0625 0.6341 0.045*
H11B 0.6988 0.1313 0.7465 0.045*
O11 0.87114 (9) 0.40074 (9) 0.46855 (9) 0.0362 (2)
C12 0.83867 (16) 0.50226 (13) 0.49898 (14) 0.0407 (4)
H12A 0.7743 0.5375 0.4326 0.049*
H12B 0.9100 0.5511 0.5296 0.049*
O13 0.79616 (10) 0.48304 (9) 0.58078 (10) 0.0391 (3)
C3A 0.77539 (12) 0.37264 (11) 0.57687 (12) 0.0280 (3)
C14 0.71953 (12) 0.31497 (12) 0.62874 (12) 0.0312 (3)
H14 0.6897 0.3498 0.6751 0.037*
C15 0.70819 (12) 0.20229 (12) 0.61057 (12) 0.0299 (3)
C16 0.75523 (12) 0.15362 (12) 0.54436 (12) 0.0316 (3)
H16 0.7471 0.0773 0.5330 0.038*
C17 0.81427 (12) 0.21356 (12) 0.49382 (11) 0.0311 (3)
H17 0.8479 0.1795 0.4501 0.037*
C7A 0.82108 (11) 0.32314 (12) 0.51047 (11) 0.0269 (3)
C47 0.15968 (12) 0.18798 (11) 0.55740 (11) 0.0273 (3)
O47 0.08510 (9) 0.19648 (11) 0.45924 (8) 0.0426 (3)
C41 0.11656 (11) 0.15520 (11) 0.64264 (10) 0.0240 (3)
C42 0.09914 (11) 0.22960 (10) 0.71238 (10) 0.0236 (3)
Cl42 0.13921 (3) 0.36508 (3) 0.71225 (3) 0.03486 (11)
C43 0.04921 (11) 0.19988 (11) 0.78313 (11) 0.0261 (3)
H43 0.0384 0.2518 0.8306 0.031*
C44 0.01549 (11) 0.09273 (12) 0.78272 (11) 0.0276 (3)
Cl44 −0.04771 (4) 0.05479 (4) 0.87079 (3) 0.04291 (12)
C45 0.02990 (12) 0.01613 (11) 0.71408 (12) 0.0310 (3)
H45 0.0052 −0.0570 0.7143 0.037*
C46 0.08095 (12) 0.04794 (11) 0.64495 (12) 0.0291 (3)
H46 0.0920 −0.0044 0.5980 0.035*

1-[(1,3-Benzodioxol-5-yl)methyl]-4-(2,4-dichlorobenzoyl)piperazine (III). Atomic displacement parameters (Å2)

U11 U22 U33 U12 U13 U23
N1 0.0239 (5) 0.0337 (6) 0.0344 (6) 0.0016 (5) 0.0165 (5) 0.0087 (5)
C2 0.0262 (6) 0.0420 (8) 0.0328 (7) −0.0015 (6) 0.0135 (6) 0.0125 (6)
C3 0.0253 (6) 0.0480 (9) 0.0241 (6) −0.0042 (6) 0.0119 (5) 0.0031 (6)
N4 0.0243 (5) 0.0478 (7) 0.0239 (5) 0.0012 (5) 0.0135 (5) 0.0061 (5)
C5 0.0304 (7) 0.0575 (10) 0.0312 (7) 0.0080 (7) 0.0194 (6) 0.0154 (7)
C6 0.0313 (7) 0.0454 (9) 0.0332 (7) 0.0022 (6) 0.0208 (6) 0.0042 (6)
C11 0.0294 (7) 0.0333 (8) 0.0526 (9) 0.0061 (6) 0.0217 (7) 0.0129 (7)
O11 0.0389 (6) 0.0424 (6) 0.0378 (6) −0.0031 (5) 0.0265 (5) 0.0000 (5)
C12 0.0499 (9) 0.0396 (8) 0.0452 (9) −0.0087 (7) 0.0326 (8) −0.0021 (7)
O13 0.0537 (6) 0.0300 (5) 0.0509 (6) −0.0066 (5) 0.0388 (6) −0.0041 (5)
C3A 0.0256 (6) 0.0292 (7) 0.0320 (7) 0.0002 (5) 0.0153 (6) −0.0009 (5)
C14 0.0307 (7) 0.0328 (7) 0.0389 (8) 0.0036 (6) 0.0235 (6) 0.0016 (6)
C15 0.0214 (6) 0.0319 (7) 0.0377 (7) 0.0051 (5) 0.0143 (6) 0.0062 (6)
C16 0.0250 (6) 0.0287 (7) 0.0378 (8) 0.0046 (5) 0.0110 (6) −0.0008 (6)
C17 0.0255 (6) 0.0386 (8) 0.0291 (7) 0.0053 (6) 0.0120 (5) −0.0041 (6)
C7A 0.0193 (6) 0.0379 (7) 0.0241 (6) −0.0003 (5) 0.0103 (5) 0.0004 (5)
C47 0.0259 (6) 0.0336 (7) 0.0251 (6) 0.0026 (5) 0.0137 (5) −0.0010 (5)
O47 0.0286 (5) 0.0743 (8) 0.0238 (5) 0.0021 (5) 0.0106 (4) 0.0031 (5)
C41 0.0186 (5) 0.0306 (7) 0.0226 (6) 0.0011 (5) 0.0090 (5) −0.0002 (5)
C42 0.0232 (6) 0.0246 (6) 0.0233 (6) −0.0024 (5) 0.0105 (5) 0.0000 (5)
Cl42 0.0493 (2) 0.02548 (18) 0.03616 (19) −0.00753 (14) 0.02471 (17) −0.00147 (13)
C43 0.0246 (6) 0.0315 (7) 0.0237 (6) −0.0015 (5) 0.0121 (5) −0.0013 (5)
C44 0.0211 (6) 0.0351 (7) 0.0261 (6) −0.0021 (5) 0.0101 (5) 0.0063 (5)
Cl44 0.0431 (2) 0.0533 (2) 0.0397 (2) −0.01166 (17) 0.02503 (17) 0.00825 (17)
C45 0.0276 (7) 0.0253 (7) 0.0361 (7) −0.0013 (5) 0.0105 (6) 0.0046 (6)
C46 0.0274 (6) 0.0271 (7) 0.0311 (7) 0.0039 (5) 0.0115 (5) −0.0025 (5)

1-[(1,3-Benzodioxol-5-yl)methyl]-4-(2,4-dichlorobenzoyl)piperazine (III). Geometric parameters (Å, º)

N1—C6 1.4540 (19) O13—C3A 1.3787 (17)
N1—C2 1.4600 (17) C3A—C14 1.3701 (19)
N1—C11 1.4665 (17) C3A—C7A 1.3839 (19)
C2—C3 1.512 (2) C14—C15 1.404 (2)
C2—H2A 0.9900 C14—H14 0.9500
C2—H2B 0.9900 C15—C16 1.389 (2)
C3—N4 1.4660 (17) C16—C17 1.400 (2)
C3—H3A 0.9900 C16—H16 0.9500
C3—H3B 0.9900 C17—C7A 1.363 (2)
N4—C47 1.3462 (17) C17—H17 0.9500
N4—C5 1.4658 (17) C47—O47 1.2276 (17)
C5—C6 1.518 (2) C47—C41 1.5088 (17)
C5—H5A 0.9900 C41—C42 1.3890 (18)
C5—H5B 0.9900 C41—C46 1.3950 (19)
C6—H6A 0.9900 C42—C43 1.3852 (17)
C6—H6B 0.9900 C42—Cl42 1.7383 (13)
C11—C15 1.5138 (19) C43—C44 1.381 (2)
C11—H11A 0.9900 C43—H43 0.9500
C11—H11B 0.9900 C44—C45 1.380 (2)
O11—C7A 1.3817 (17) C44—Cl44 1.7370 (13)
O11—C12 1.4242 (19) C45—C46 1.384 (2)
C12—O13 1.4249 (17) C45—H45 0.9500
C12—H12A 0.9900 C46—H46 0.9500
C12—H12B 0.9900
C6—N1—C2 109.49 (11) H12A—C12—H12B 108.4
C6—N1—C11 112.16 (12) C3A—O13—C12 105.01 (11)
C2—N1—C11 111.54 (11) C14—C3A—O13 128.09 (13)
N1—C2—C3 110.56 (11) C14—C3A—C7A 122.22 (13)
N1—C2—H2A 109.5 O13—C3A—C7A 109.69 (12)
C3—C2—H2A 109.5 C3A—C14—C15 117.23 (13)
N1—C2—H2B 109.5 C3A—C14—H14 121.4
C3—C2—H2B 109.5 C15—C14—H14 121.4
H2A—C2—H2B 108.1 C16—C15—C14 119.91 (13)
N4—C3—C2 110.58 (12) C16—C15—C11 121.81 (13)
N4—C3—H3A 109.5 C14—C15—C11 118.28 (13)
C2—C3—H3A 109.5 C15—C16—C17 122.09 (14)
N4—C3—H3B 109.5 C15—C16—H16 119.0
C2—C3—H3B 109.5 C17—C16—H16 119.0
H3A—C3—H3B 108.1 C7A—C17—C16 116.72 (13)
C47—N4—C5 120.16 (11) C7A—C17—H17 121.6
C47—N4—C3 125.09 (11) C16—C17—H17 121.6
C5—N4—C3 114.32 (11) C17—C7A—O11 128.57 (12)
N4—C5—C6 110.25 (12) C17—C7A—C3A 121.80 (13)
N4—C5—H5A 109.6 O11—C7A—C3A 109.63 (12)
C6—C5—H5A 109.6 O47—C47—N4 123.39 (13)
N4—C5—H5B 109.6 O47—C47—C41 118.97 (12)
C6—C5—H5B 109.6 N4—C47—C41 117.62 (11)
H5A—C5—H5B 108.1 C42—C41—C46 117.74 (12)
N1—C6—C5 110.42 (12) C42—C41—C47 122.74 (12)
N1—C6—H6A 109.6 C46—C41—C47 119.22 (12)
C5—C6—H6A 109.6 C43—C42—C41 122.06 (12)
N1—C6—H6B 109.6 C43—C42—Cl42 117.72 (10)
C5—C6—H6B 109.6 C41—C42—Cl42 120.22 (10)
H6A—C6—H6B 108.1 C44—C43—C42 118.17 (12)
N1—C11—C15 111.53 (11) C44—C43—H43 120.9
N1—C11—H11A 109.3 C42—C43—H43 120.9
C15—C11—H11A 109.3 C45—C44—C43 121.85 (12)
N1—C11—H11B 109.3 C45—C44—Cl44 119.64 (11)
C15—C11—H11B 109.3 C43—C44—Cl44 118.50 (11)
H11A—C11—H11B 108.0 C44—C45—C46 118.71 (13)
C7A—O11—C12 105.00 (10) C44—C45—H45 120.6
O11—C12—O13 108.54 (12) C46—C45—H45 120.6
O11—C12—H12A 110.0 C45—C46—C41 121.47 (13)
O13—C12—H12A 110.0 C45—C46—H46 119.3
O11—C12—H12B 110.0 C41—C46—H46 119.3
O13—C12—H12B 110.0
C6—N1—C2—C3 −61.31 (16) C12—O11—C7A—C17 172.09 (14)
C11—N1—C2—C3 173.95 (13) C12—O11—C7A—C3A −8.17 (15)
N1—C2—C3—N4 55.00 (16) C14—C3A—C7A—C17 −0.7 (2)
C2—C3—N4—C47 136.85 (14) O13—C3A—C7A—C17 178.96 (13)
C2—C3—N4—C5 −50.77 (17) C14—C3A—C7A—O11 179.50 (12)
C47—N4—C5—C6 −136.22 (14) O13—C3A—C7A—O11 −0.81 (15)
C3—N4—C5—C6 50.99 (18) C5—N4—C47—O47 5.4 (2)
C2—N1—C6—C5 61.64 (16) C3—N4—C47—O47 177.41 (14)
C11—N1—C6—C5 −173.97 (12) C5—N4—C47—C41 −175.89 (13)
N4—C5—C6—N1 −55.75 (17) C3—N4—C47—C41 −3.9 (2)
C6—N1—C11—C15 69.26 (16) O47—C47—C41—C42 −100.59 (16)
C2—N1—C11—C15 −167.51 (13) N4—C47—C41—C42 80.68 (17)
C7A—O11—C12—O13 14.03 (16) O47—C47—C41—C46 72.85 (18)
O11—C12—O13—C3A −14.51 (16) N4—C47—C41—C46 −105.88 (15)
C12—O13—C3A—C14 −170.92 (15) C46—C41—C42—C43 0.52 (19)
C12—O13—C3A—C7A 9.41 (16) C47—C41—C42—C43 174.06 (12)
O13—C3A—C14—C15 179.33 (14) C46—C41—C42—Cl42 −178.99 (10)
C7A—C3A—C14—C15 −1.0 (2) C47—C41—C42—Cl42 −5.46 (17)
C3A—C14—C15—C16 1.5 (2) C41—C42—C43—C44 −0.42 (19)
C3A—C14—C15—C11 −179.07 (12) Cl42—C42—C43—C44 179.11 (10)
N1—C11—C15—C16 −132.47 (14) C42—C43—C44—C45 −0.3 (2)
N1—C11—C15—C14 48.08 (19) C42—C43—C44—Cl44 −179.77 (10)
C14—C15—C16—C17 −0.2 (2) C43—C44—C45—C46 0.8 (2)
C11—C15—C16—C17 −179.64 (13) Cl44—C44—C45—C46 −179.70 (10)
C15—C16—C17—C7A −1.5 (2) C44—C45—C46—C41 −0.7 (2)
C16—C17—C7A—O11 −178.31 (12) C42—C41—C46—C45 0.03 (19)
C16—C17—C7A—C3A 2.0 (2) C47—C41—C46—C45 −173.74 (12)

Funding Statement

This work was funded by University Grants Commission grants BSR Faculty Fellowship and Rajeev Gandhi Fellowship.

References

  1. Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N.-L. (1995). Angew. Chem. Int. Ed. Engl. 34, 1555–1573.
  2. Bruker (2004). APEX2. Bruker AXS Inc., Madison, Wisconsin, USA.
  3. Bruker (2013). SAINT, Bruker AXS Inc., Madison, Wisconsin, USA.
  4. Bruker (2015). SADABS, Bruker AXS Inc., Madison, Wisconsin, USA.
  5. Duncton, M. A. J., Roffey, J. R. A., Hamlyn, R. J. & Adams, D. R. (2006). Tetrahedron Lett. 47, 2549–2552.
  6. Etter, M. C. (1990). Acc. Chem. Res. 23, 120–126.
  7. Etter, M. C., MacDonald, J. C. & Bernstein, J. (1990). Acta Cryst. B46, 256–262. [DOI] [PubMed]
  8. Ferguson, G., Glidewell, C., Gregson, R. M. & Meehan, P. R. (1998a). Acta Cryst. B54, 129–138.
  9. Ferguson, G., Glidewell, C., Gregson, R. M. & Meehan, P. R. (1998b). Acta Cryst. B54, 139–150.
  10. Flack, H. D. (1983). Acta Cryst. A39, 876–881.
  11. Flack, H. D. & Bernardinelli, G. (2000). J. Appl. Cryst. 33, 1143–1148.
  12. Gregson, R. M., Glidewell, C., Ferguson, G. & Lough, A. J. (2000). Acta Cryst. B56, 39–57. [DOI] [PubMed]
  13. Hamid, M. H. S. A. & Williams, J. M. J. (2007). Tetrahedron Lett. 48, 8263–8265.
  14. Hooft, R. W. W., Straver, L. H. & Spek, A. L. (2008). J. Appl. Cryst. 41, 96–103. [DOI] [PMC free article] [PubMed]
  15. Kavitha, C. N., Kaur, M., Anderson, B. J., Jasinski, J. P. & Yathirajan, H. S. (2014a). Acta Cryst. E70, o208–o209. [DOI] [PMC free article] [PubMed]
  16. Kavitha, C. N., Kaur, M., Anderson, B. J., Jasinski, J. P. & Yathirajan, H. S. (2014b). Acta Cryst. E70, o270–o271. [DOI] [PMC free article] [PubMed]
  17. Kavitha, C. N., Kaur, M., Anderson, B. J., Jasinski, J. P. & Yathirajan, H. S. (2014c). Acta Cryst. E70, o283–o284. [DOI] [PMC free article] [PubMed]
  18. Li, Y.-F. (2011). Acta Cryst. E67, o2575. [DOI] [PMC free article] [PubMed]
  19. Mahesha, N., Yathirajan, H. S., Furuya, T., Akitsu, T. & Glidewell, C. (2019). Acta Cryst. E75, 129–133. [DOI] [PMC free article] [PubMed]
  20. Millan, M. J., Cussac, D., Milligan, G., Carr, C., Audinot, V., Gobert, A., Lejeune, F., Rivet, J.-M., Brocco, M., Duqueyroix, D., Nicolas, J.-P., Boutin, J. A. & Newman-Tancredi, A. (2001). J. Pharmacol. Exp. Ther. 297, 876–887. [PubMed]
  21. Nyburg, S. C. & Faerman, C. H. (1985). Acta Cryst. B41, 274–279.
  22. Parsons, S., Flack, H. D. & Wagner, T. (2013). Acta Cryst. B69, 249–259. [DOI] [PMC free article] [PubMed]
  23. Rondot, P. & Ziegler, M. (1992). J. Neurol. 239, S28–S34. [DOI] [PubMed]
  24. Sheldrick, G. M. (2015). Acta Cryst. C71, 3–8.
  25. Spek, A. L. (2009). Acta Cryst. D65, 148–155. [DOI] [PMC free article] [PubMed]
  26. Wood, P. A., Allen, F. H. & Pidcock, E. (2009). CrystEngComm, 11, 1563–1571.
  27. Wu, C., Li, J., Wei, H., Hang, Y. & Jiang, Y. (2013). Acta Cryst. E69, o1140. [DOI] [PMC free article] [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Crystal structure: contains datablock(s) global, I, II, III. DOI: 10.1107/S2056989019000458/zl2747sup1.cif

e-75-00202-sup1.cif (876.5KB, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989019000458/zl2747Isup2.hkl

e-75-00202-Isup2.hkl (293.2KB, hkl)

Structure factors: contains datablock(s) II. DOI: 10.1107/S2056989019000458/zl2747IIsup3.hkl

e-75-00202-IIsup3.hkl (298.6KB, hkl)

Structure factors: contains datablock(s) III. DOI: 10.1107/S2056989019000458/zl2747IIIsup4.hkl

e-75-00202-IIIsup4.hkl (323.2KB, hkl)

Supporting information file. DOI: 10.1107/S2056989019000458/zl2747Isup5.cml

Supporting information file. DOI: 10.1107/S2056989019000458/zl2747IIsup6.cml

Supporting information file. DOI: 10.1107/S2056989019000458/zl2747IIIsup7.cml

CCDC references: 1889708, 1889709, 1889710

Additional supporting information: crystallographic information; 3D view; checkCIF report


Articles from Acta Crystallographica Section E: Crystallographic Communications are provided here courtesy of International Union of Crystallography

RESOURCES